Indian Journal of Pharmaceutical Sciences
Users online: 49
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  


 
SHORT COMMUNICATION
Year : 2008  |  Volume : 70  |  Issue : 1  |  Page : 94-96
Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery


Department of Pharmaceutics, Al-Ameen College of Pharmacy, Hosur Road, Bangalore - 560 027, India

Date of Submission03-Oct-2006
Date of Decision26-Jul-2007
Date of Acceptance30-Jan-2008

Correspondence Address:
N S Chandrashekar
Department of Pharmaceutics, Al-Ameen College of Pharmacy, Hosur Road, Bangalore - 560 027
India
Login to access the Email id


DOI: 10.4103/0250-474X.40340

PMID: 20390089

Get Permissions

   Abstract 

Skin of an average adult body covers a surface of approximately 2 m2 and receives about one-third of the blood circulating through the body. The transdermal route of administration cannot be employed for a large number of drugs. The rationality of drug selection based on pharmacokinetic parameters and physicochemical properties of the drug are the important factors to be considered for deciding its suitability of drug for delivery by transdermal route.


Keywords: Transdermal delivery, Physicochemical, Pharmacokinetics


How to cite this article:
Chandrashekar N S, Shobha Rani R H. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci 2008;70:94-6

How to cite this URL:
Chandrashekar N S, Shobha Rani R H. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci [serial online] 2008 [cited 2014 Jul 23];70:94-6. Available from: http://www.ijpsonline.com/text.asp?2008/70/1/94/40340


Over the past three decades, developing controlled drug delivery has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired adverse effect, of a drug is dependent on the concentration of the drug at the site of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action. Skin of an average adult body covers a surface of approximately 2 m 2 and receives about one-third of the blood circulating through the body. Skin contains an uppermost layer, epidermis which has morphologically distinct regions; basal layer, spiny layer, stratum granulosum and upper most stratum corneum, it consists of highly cornified (dead) cells embedded in a continuous matrix of lipid membranous sheets. These extracellular membranes are unique in their compositions and are composed of ceramides, cholesterol and free fatty acids. The human skin surface is known to contain, on an average, 10-70 hair follicles and 200-250 sweat ducts on every square centimeters of the skin area [1] . It is one of the most readily accessible organs of the human body. The potential of using the intact skin as the port of drug administration to the human body has been recognised for several decades, but skin is a very difficult barrier to the ingress of materials allowing only small quantities of a drug to penetrate over a period of time [2] .

The transdermal route of administration cannot be employed for a large number of drugs. The objective of this paper is to focus on the rationality of drug selection based on pharmacokinetic parameters and physicochemical properties of the drug. Physiochemical factors such as solubility, crystallinity, molecular weight <400, polarity, melting point <200, partition coefficient Log P (octanol-water) between -1.0 to 4 must be considered [3] [Table - 1]. Biological factor should also be considered such as skin irritation, site of application of the patch e.g. scopolamine patch for motion sickness is applied backside of the ear and Transderm-Nitro is applied on the chest. When a pharmacologically active material has to be presented to the skin, an occlusive or allergic response is significant, limits have to be determined for the acceptability of the undesired effect [4] . The pharmacokinetic information of the drug is a critical factor in deciding its suitability for delivery by the transdermal route as it is suitable only for drugs whose daily dose is in few milligrams. The resulting plasma concentration of active agent depends on the clearance; however, if one assumes a small volume of distribution and relatively long half-life, plasma level in excess of few micrograms per milliliter is very unlikely. Another important factor is the half-life, (e.g., nitroglycerin t 1/2 is 3 min) which provides information on the disposition of a drug in our body other parameters such as effective plasma level; also determine whether a transdermal delivery can be developed or not [Table - 2].

One can estimate the skin input rate of a drug required from its transdermal system based on volume of distribution (Vd), total body clearance (Cl T ) and steady state or therapeutic concentration (CPss) under steady state conditions, the drug input rate from its transdermal system is expected to be equal to its output rate, determined by total body clearance multiplied by the therapeutic plasma concentration. This relationship can be expressed using following mass balance equation; input rate = dosing rate x bioavaliable factor (F), output rate = total body clearance x steady state plasma concentration and input rate = output rate or F x dosing rate = CL TxCPss...1, where CL T is total body clearance, CPss is average target plasma concentration. Since epidermis is metabolically inert, F = 1. For most drug compounds, total body clearance is the product of volume of distribution and total elimination rate (K E ), CL T = K E x V d...2. Thus the required flux from a transdermal patch can be calculated by normalizing the dosing rate Eqn. 1 for the surface area (A, cm 2 ); Flux, Jss = CL T x CPss/A...3.

Here is an example to determine the feasibility of the anticonvulsant drug, primidone for 10 cm 2 transdermal patch, currently administered 750 mg/day as a tablet. The required flux (Jss) or input rate can be calculated from the pharmacokinetic properties of the drug, therapeutic concentration 10 μg/ml, total body clearance and elimination half-life which was determined to be 0.78 ml/kg/min and 4 h, respectively, permeability coefficient is 5 x 10 -3 and saturation solubility is 1 mg/ml 5 .

Since the drug is absorbed completely, F = 1, the required output rate of primidone can be calculated from Eqn. 3; CL = 0.78 ml/kg/min x 70 kg (normal body weight) = 54.6 ml/min = 3276 ml/h. Out put rate = (3276 ml/hx10 μg/h) ÷ 0 cm 2 = 3276 μg/cm2 /h. The input rate, transdermal flux in this case, is 3.3 mg/cm 2 /h is required from the transdermal patch of primidone. The mass of drug that can be delivered across the skin is M = P estimate x Cs = 5x10 -31 = 5 μg/cm2 /h the area of the patch required to deliver therapeutic plasma level of primidone is Jss ÷ M = 3300 μg/h ÷ 5 μg/cm2 /h = 660 cm 2

From the above calculations, it is seen that a large area of the body viz. 600 cm 2 is required to deliver the therapeutic dose of primidone from the transdermal patch which is not desirable. Thus transdermal patch of 10 cm 2 would not be feasible for primidone. This paper makes an attempt to give information about the suitability of the drug(s) for the transdermal drug delivery systems based on their physiochemical and pharmacokinetic parameters.[5]


   Acknowledgments Top


We are highly thankful to Prof. B.G. Shivananda, Principal, Al-Ameen College of Pharmacy for his continuous encouragement, Indian Pharmaceutical Association for IPA-IRF scholarship, 3M India and 3M USA for their support in research work.

 
   References Top

1.Torotora G. Principles of Anatomy and Physiology. 10th ed. New York: John Wiely and sons; 2003.  Back to cited text no. 1    
2.Chein YW. Novel Drug Delivery Systems Revised and expanded. 2nd ed. New York: Marcel Dekker Inc; 2005.  Back to cited text no. 2    
3.Panchagnula R. Transdermal delivery of drugs. Indian J Pharmacol 1997;29:140-56.  Back to cited text no. 3    
4.Naik A, Kalia YN, Guy RH. Transdermal: overcoming the skin's barrier function. PSTT 2000;3:318-26.  Back to cited text no. 4    
5.Jasti BR, Abraham W, Ghosh TK. Transdermal and Topical drug delivery systems. In : Ghosh TK, Jasti BR, editors. Theory and Practice of Contemporary Pharmaceutics. 1st ed. Florida: CRC Press; 2005. p. 423-53.  Back to cited text no. 5    



 
 
    Tables

  [Table - 1], [Table - 2]

This article has been cited by
1 Lecithin-based nanostructured gels for skin delivery: An update on state of art and recent applications
Yosra S.R. Elnaggar,Wessam M. El-Refaie,Magda A. El-Massik,Ossama Y. Abdallah
Journal of Controlled Release. 2014; 180: 10
[Pubmed]
2 Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers
Srinivas Mutalik,Pallavi K. Shetty,Aravind Kumar,Rohit Kalra,Harendra S. Parekh
Drug Delivery. 2013; : 1
[Pubmed]
3 Formulation and evaluation considerations of transdermal drug delivery system
Patel, R.P., Baria, A.H.
International Journal of Pharmaceutical Research. 2011; 3(1): 1-9
[Pubmed]
4 Transdermal Drug Delivery System-Design and Evaluation
Keleb, E., Sharma, R.K., B mosa, E., Z aljahwi, A.
International Journal of Advances in Pharmaceutical Sciences. 2010; 1(3): 201-211
[Pubmed]
5 Health care practitioners? perceptions of transdermal therapeutic systems in Palestinian territories
Naser, Z.A.
Asian Journal of Pharmaceutics. 2009; 3(4): 304-308
[Pubmed]



 

Top
Print this article  Email this article
 
  Search
   
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (178 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Acknowledgments
    References
    Article Tables

 Article Access Statistics
    Viewed4286    
    Printed86    
    Emailed1    
    PDF Downloaded858    
    Comments [Add]    
    Cited by others 5    

Recommend this journal